Trademark: 86242714
Word
EPIVARINEX
Status
Dead
Status Code
710
Status Date
Friday, November 26, 2021
Serial Number
86242714
Registration Number
4726409
Registration Date
Tuesday, April 28, 2015
Mark Type
4000
Filing Date
Friday, April 4, 2014
Published for Opposition
Tuesday, February 10, 2015
Cancellation Date
Friday, November 26, 2021

Trademark Owner History
GW RESEARCH LIMITED -
GW Pharma Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes

Trademark Events
Nov 26, 2021
Cancelled Sec. 8 (6-Yr)
Sep 15, 2021
Teas Change Of Correspondence Received
Sep 15, 2021
Teas Change Of Domestic Representatives Address
Sep 15, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 28, 2021
Assignment Of Ownership Not Updated Automatically
Apr 28, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 25, 2018
Automatic Update Of Assignment Of Ownership
Dec 12, 2017
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 12, 2017
Teas Change Of Owner Address Received
Nov 29, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 29, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 28, 2015
Registered-Principal Register
Feb 10, 2015
Official Gazette Publication Confirmation E-Mailed
Feb 10, 2015
Published For Opposition
Jan 21, 2015
Notification Of Notice Of Publication E-Mailed
Jan 7, 2015
Law Office Publication Review Completed
Jan 7, 2015
Approved For Pub - Principal Register
Dec 29, 2014
Teas/Email Correspondence Entered
Dec 29, 2014
Correspondence Received In Law Office
Dec 29, 2014
Assigned To Lie
Dec 12, 2014
Teas Response To Office Action Received
Jun 23, 2014
Notification Of Non-Final Action E-Mailed
Jun 23, 2014
Non-Final Action E-Mailed
Jun 23, 2014
Non-Final Action Written
Jun 20, 2014
Assigned To Examiner
Apr 17, 2014
New Application Office Supplied Data Entered In Tram
Apr 8, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24